ATE548658T1 - Peptidmarker zur diagnose von präeklampsie - Google Patents

Peptidmarker zur diagnose von präeklampsie

Info

Publication number
ATE548658T1
ATE548658T1 AT08705059T AT08705059T ATE548658T1 AT E548658 T1 ATE548658 T1 AT E548658T1 AT 08705059 T AT08705059 T AT 08705059T AT 08705059 T AT08705059 T AT 08705059T AT E548658 T1 ATE548658 T1 AT E548658T1
Authority
AT
Austria
Prior art keywords
preeclampsia
diagnosis
peptide markers
calcyclin
marker
Prior art date
Application number
AT08705059T
Other languages
English (en)
Inventor
Theo Luider
Smitt Petrus Sillevis
Eric Adrianus Petrus Steegers
Original Assignee
Univ Erasmus Medical Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Erasmus Medical Ct filed Critical Univ Erasmus Medical Ct
Application granted granted Critical
Publication of ATE548658T1 publication Critical patent/ATE548658T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT08705059T 2007-01-12 2008-01-14 Peptidmarker zur diagnose von präeklampsie ATE548658T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/NL2007/050014 WO2008085024A1 (en) 2007-01-12 2007-01-12 Identification and detection of peptides relating to specific disorders
PCT/NL2008/000021 WO2008085036A1 (en) 2007-01-12 2008-01-14 Peptide markers for diagnosis of preeclampsia

Publications (1)

Publication Number Publication Date
ATE548658T1 true ATE548658T1 (de) 2012-03-15

Family

ID=38171286

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08705059T ATE548658T1 (de) 2007-01-12 2008-01-14 Peptidmarker zur diagnose von präeklampsie

Country Status (7)

Country Link
US (2) US20100291612A1 (de)
EP (2) EP2118662A1 (de)
AT (1) ATE548658T1 (de)
AU (2) AU2008203970A1 (de)
CA (2) CA2674737A1 (de)
NZ (1) NZ578262A (de)
WO (4) WO2008085024A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2543341T3 (es) 2005-09-13 2015-08-18 National Research Council Of Canada Métodos y composiciones para modular la actividad de células tumorales
SG10201704689XA (en) 2008-01-18 2017-07-28 Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
US20110247404A1 (en) * 2008-06-25 2011-10-13 University Of Utah Research Foundation Identifying and quantifying biomarkers associated with preeclampsia
IT1392551B1 (it) * 2008-11-25 2012-03-09 Bioindustry Park Del Canavese S P A Biomarcatori per la diagnosi e per rilevare la progressione di malattie neurodegenerative, in particolare della sclerosi laterale amiotrofica
CA2928846A1 (en) 2009-11-24 2011-06-03 Alethia Biotherapeutics Inc. Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
US9595099B2 (en) * 2010-02-26 2017-03-14 Carolyn M Salafia Automated placental measurement
MX2013000917A (es) 2010-07-23 2013-07-05 Harvard College Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
SG10201505723UA (en) 2010-07-23 2015-09-29 Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
CA2806304A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
KR101449100B1 (ko) 2011-04-21 2014-10-13 가톨릭대학교 산학협력단 신경세포 데브리스 제거용 오스테오폰틴
EP2766726A1 (de) 2011-10-14 2014-08-20 Aarhus Universitet Diagnostischr und prognostische verwendung von prombp-komplexen
CA2862739A1 (en) 2012-02-22 2013-08-29 Alethia Biotherapeutics Inc. Co-use of a clusterin inhibitor with an egfr inhibitor to treat cancer
US20150087553A1 (en) * 2012-04-13 2015-03-26 Bioscreening and Diagnostics, LLC Early trimester screening for early- and late-onset preeclampsia
CN104603289A (zh) 2012-06-15 2015-05-06 哈里·斯泰利 检测疾病或病状的方法
EA201590024A1 (ru) 2012-06-15 2015-05-29 Гарри Стилли Способы определения заболеваний или состояний с применением циркулирующих болезненных клеток
KR102103319B1 (ko) * 2012-06-26 2020-04-22 바이오디식스, 인크. 면역반응 발생 요법으로 치료하기 위해 암환자들의 선택, 및 선택해제를 위한 질량-스펙트럼법
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
EP4428251A3 (de) 2014-09-11 2024-12-18 Immunis.AI, Inc. Verfahren zum nachweis von prostatakrebs
RU2724013C2 (ru) 2015-06-19 2020-06-18 Сера Прогностикс, Инк. Пары биологических маркеров для предсказания преждевременных родов
FR3038984B1 (fr) * 2015-07-15 2020-01-10 Universite de Bordeaux Analyse proteomique de compartiments subcellulaires
WO2018151938A2 (en) * 2017-02-17 2018-08-23 The Methodist Hospital Compositions and methods of determining a level of infection in a subject
WO2019036032A1 (en) 2017-08-18 2019-02-21 Sera Prognostics, Inc PREGNANCY CLOCK PROTEINS FOR PREDICTING THE DATE AND MOMENT OF BIRTH
AU2018324195B2 (en) 2017-09-01 2024-12-12 Venn Biosciences Corporation Identification and use of glycopeptides as biomarkers for diagnosis and treatment monitoring
JPWO2019202767A1 (ja) * 2018-04-17 2021-05-13 国立大学法人大阪大学 抗線維化剤及び線維症のバイオマーカー

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185243A (en) * 1988-08-25 1993-02-09 Syntex (U.S.A.) Inc. Method for detection of specific nucleic acid sequences
US5436132A (en) * 1993-02-13 1995-07-25 Amano Pharmaceutical Co., Ltd. Quantitative determination of tenascin as glioma marker
ITMI20011833A1 (it) * 2001-08-31 2003-03-03 San Raffaele Centro Fond Agenti che regolano la permeabilita' vascolare
WO2004082455A2 (en) * 2003-03-18 2004-09-30 Biovision Ag Method for detecting alzheimer’s disease and corresponding peptides and detection reagents
JP2008502890A (ja) * 2004-06-18 2008-01-31 エフ.ホフマン−ラ ロシュ アーゲー 結腸直腸癌のマーカーとしてのcbp2の使用
JP2009528059A (ja) * 2006-02-28 2009-08-06 メタボロン インコーポレイテッド 筋萎縮性側索硬化症に関するバイオマーカー及びそれらを使用する方法

Also Published As

Publication number Publication date
US20100240088A1 (en) 2010-09-23
NZ578262A (en) 2012-02-24
WO2008085024A1 (en) 2008-07-17
EP2118664B1 (de) 2012-03-07
EP2118662A1 (de) 2009-11-18
WO2008085035A1 (en) 2008-07-17
CA2674737A1 (en) 2008-07-17
EP2118664A1 (de) 2009-11-18
AU2008203970A1 (en) 2008-07-17
CA2674736A1 (en) 2008-07-17
WO2008085034A1 (en) 2008-07-17
US20100291612A1 (en) 2010-11-18
WO2008085036A1 (en) 2008-07-17
AU2008203968A1 (en) 2008-07-17

Similar Documents

Publication Publication Date Title
EP2215257A4 (de) Verfahren zur diagnose von tumorerkrankungen
BR112013001752A2 (pt) método de detectar doenças ou condições usando células fagocídicas
UY32698A (es) Marcadores de riesgo para enfermedades cardiovasculares
EP2576839A4 (de) Nukleinsäurenachweis und -quantifizierung durch posthybridisierungs-kennzeichnung und universelle kodierung
DE602007011545D1 (de) Automatisches System zur Durchführung von lokalisierten Bestandsaufnahmen
DE602007001585D1 (de) Verfahren zur herstellung von kunstlatex
ATE522488T1 (de) Verfahren zur herstellung von 1,2-dichlorethan
ES2570334T3 (es) Remodelado superficial de proteínas
EP2333107A4 (de) Genexpressionsprofil als endometrialer rezeptivitätsmarker
WO2014207049A3 (de) Verfahren zur bestimmung von proteinaggregaten unter verwendung von oberflächen-fida
EP2168728A4 (de) Verfahren zur beurteilung von roboterfehlern
PH12015502849B1 (en) Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers
BR112014021993A2 (pt) detecção da variação de nucleotídeo em sequência de ácido nucleico alvo através de ensaio de clivagem e extensão de pto
DK2140269T3 (da) Proteinsignatur/markører til at detektere adenocarcinom
BRPI0920989A2 (pt) sistema de criação de plano de combinação e dotação de navio, método e programa para o mesmo
EP2306225A4 (de) Verfahren zur erkennung von direktleitungen
ATE495286T1 (de) Verfahren zur hydrolyse von polyphosphorsäure in polyareneazolfasern
ES2414290R1 (es) Metodo para el diagnostico y/o pronostico de dano renal agudo
EP2650685A3 (de) Verfahren und Kit zur Klassifizierung und Prognose von Wunden
WO2011017656A3 (en) Non-mass determined base compositions for nucleic acid detection
WO2008049063A3 (en) Method of identifying a device by gps coordinates
AR059326A1 (es) Resistencia a la mastitis
EA200801533A1 (ru) Производные антрахинона в качестве маркирующих веществ для жидкостей
WO2013009143A3 (ko) 당뇨망막병증 진단용 마커 및 이의 용도
DE602006002031D1 (de) Legenest für geflügel